Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas
To find the highest tolerable dose of JV-213 (a type of autologous CAR T cell therapy) that can be given to patients who have B-cell lymphoma that is relapsed …
LymphomasB-cell Lymphomas
Estimated
~$10 – $6,250
M.D. Anderson Cancer CenterNCT05773040
Phase 2
Phase 2 Study of Glofitamab and Gemcitabine and Oxaliplatin (Glofit-GemOx) Bridging to Lisocabtagene Maraleucel in Relapsed/Refractory Aggressive B-cell Lymphomas
The goal of this clinical trial is to assess the clinical efficacy of bridging therapy with glofitamab/gemcitabine/oxaliplatin (Glofit-GemOx) followed by lisoc…
LymphomaB-cell LymphomasRelapsed/Refractory Large B-cell Lymphoma+1 more
Estimated
~$10 – $6,250
Massachusetts General HospitalNCT07711483